CARDIOVASCULAR DISEASE RISK FACTOR ESTIMATION IN GUJARATI ASIAN INDIAN POPULATION USING FRAMINGHAM RISK EQUATION

Similar documents
Are Gujarati Asian Indians older for their vascular age as compared to their Chronological age?

Optimizing risk assessment of total cardiovascular risk What are the tools? Lars Rydén Professor Karolinska Institutet Stockholm, Sweden

EXECUTIVE SUMMARY OF THE MINOR RESEARCH PROJECT Submitted to UNIVERSITY GRANTS COMMISSION

Know Your Number Aggregate Report Single Analysis Compared to National Averages

The investigation of serum lipids and prevalence of dyslipidemia in urban adult population of Warangal district, Andhra Pradesh, India

Plasma fibrinogen level, BMI and lipid profile in type 2 diabetes mellitus with hypertension

Assessing Cardiovascular Risk to Optimally Stratify Low- and Moderate- Risk Patients. Copyright. Not for Sale or Commercial Distribution

Figure S1. Comparison of fasting plasma lipoprotein levels between males (n=108) and females (n=130). Box plots represent the quartiles distribution

Lipoprotein Particle Profile

CVD Risk Assessment. Michal Vrablík Charles University, Prague Czech Republic

Metabolic Syndrome: Why Should We Look For It?

The Effects of Moderate Intensity Exercise on Lipoprotein-Lipid Profiles of Haramaya University Community

Supplementary Online Content

Global Coronary Heart Disease Risk Assessment of U.S. Persons With the Metabolic. Syndrome. and Nathan D. Wong, PhD, MPH

Treatment of Cardiovascular Risk Factors. Kevin M Hayes D.O. F.A.C.C. First Coast Heart and Vascular Center

Small dense low-density lipoprotein is a risk for coronary artery disease in an urban Japanese cohort: The Suita study

The Metabolic Syndrome Update The Metabolic Syndrome Update. Global Cardiometabolic Risk

Identification of subjects at high risk for cardiovascular disease

The Framingham Risk Score (FRS) is widely recommended

Total risk management of Cardiovascular diseases Nobuhiro Yamada

HIGH LDL CHOLESTEROL IS NOT AN INDEPENDENT RISK FACTOR FOR HEART ATTACKS AND STROKES

Journal of the American College of Cardiology Vol. 48, No. 2, by the American College of Cardiology Foundation ISSN /06/$32.

Dyslipidaemia. Is there any new information? Dr. A.R.M. Saifuddin Ekram

Eyes on Korean Data: Lipid Management in Korean DM Patients

Risk Factors for Heart Disease

A comparative study on the fasting and post prandial lipid levels as a cardiovascular risk factor in patients with type 2 diabetes mellitus

HDL-C. J Jpn Coll Angiol, 2008, 48: NIPPON DATA80, MEGA study, JELIS, dyslipidemia, risk assessment chart

Review of guidelines for management of dyslipidemia in diabetic patients

HBA1C: PREDICTOR OF DYSLIPIDEMIA AND ATHEROGENICITY IN DIABETES MELLITUS

Modelling Reduction of Coronary Heart Disease Risk among people with Diabetes

How to Reduce Residual Risk in Primary Prevention

Northwestern University Feinberg School of Medicine Calculating the CVD Risk Score: Which Tool for Which Patient?

ATP IV: Predicting Guideline Updates

John J.P. Kastelein MD PhD Professor of Medicine Dept. of Vascular Medicine Academic Medial Center / University of Amsterdam

Update on Lipid Management in Cardiovascular Disease: How to Understand and Implement the New ACC/AHA Guidelines

Know Your Number Aggregate Report Comparison Analysis Between Baseline & Follow-up

DYSLIPIDAEMIC PATTERN OF PATIENTS WITH TYPE 2 DIABETES MELLITUS. Eid Mohamed, Mafauzy Mohamed*, Faridah Abdul Rashid

Prediction of Cardiovascular Disease in suburban population of 3 municipalities in Nepal

Metabolic Syndrome among Type-2 Diabetic Patients in Benghazi- Libya: A pilot study. Arab Medical University. Benghazi, Libya

Impact of metabolic syndrome on hospital in acute myocardial infarction patients

Impact of Physical Activity on Metabolic Change in Type 2 Diabetes Mellitus Patients

THE EFFECT OF VITAMIN-C THERAPY ON HYPERGLYCEMIA, HYPERLIPIDEMIA AND NON HIGH DENSITY LIPOPROTEIN LEVEL IN TYPE 2 DIABETES

CONTRIBUTING FACTORS FOR STROKE:

Established Risk Factors for Coronary Heart Disease (CHD)

Andrejs Kalvelis 1, MD, PhD, Inga Stukena 2, MD, Guntis Bahs 3 MD, PhD & Aivars Lejnieks 4, MD, PhD ABSTRACT INTRODUCTION. Riga Stradins University

1. Which one of the following patients does not need to be screened for hyperlipidemia:

How would you manage Ms. Gold

Clinical Recommendations: Patients with Periodontitis

Frequency of Metabolic Syndrome on Diabetes Mellitus Patients in Surabaya

Cardiovascular Complications of Diabetes

Diabetes Care 31: , 2008

Using Cardiovascular Risk to Guide Antihypertensive Treatment Implications For The Pre-elderly and Elderly

PIEDMONT ACCESS TO HEALTH SERVICES, INC. Guidelines for Screening and Management of Dyslipidemia

Preclinical Detection of CAD: Is it worth the effort? Michael H. Crawford, MD

The New Gold Standard for Lipoprotein Analysis. Advanced Testing for Cardiovascular Risk

Low-density lipoproteins cause atherosclerotic cardiovascular disease (ASCVD) 1. Evidence from genetic, epidemiologic and clinical studies

Diabetes, Diet and SMI: How can we make a difference?

CVD Prevention, Who to Consider

SCIENTIFIC STUDY REPORT

Society for Behavioral Medicine 33 rd Annual Meeting New Orleans, LA

Dyslipidemia and the Use of Statins. Troy L Randle, DO, FACC, FACOI

Andrew Cohen, MD and Neil S. Skolnik, MD INTRODUCTION

Atherogenic Index as a Predictor of Cardiovascular Risk among Women with Different Grades of Obesity

Preventing Myocardial Infarction in the Young Adult in the First Place: How Do the National Cholesterol Education Panel III Guidelines Perform?

The Metabolic Syndrome: Is It A Valid Concept? YES

The Metabolic Syndrome Update The Metabolic Syndrome: Overview. Global Cardiometabolic Risk

Cardiovascular Disease Prevention: Current Knowledge, Future Directions

Guidelines on cardiovascular risk assessment and management

Approach to Dyslipidemia among diabetic patients

MOLINA HEALTHCARE OF CALIFORNIA

Lipid Management 2013 Statin Benefit Groups

Low HDL-levels: leave it or treat it?

Impact of Chronicity on Lipid Profile of Type 2 Diabetics

Diabetes Mellitus: A Cardiovascular Disease

The Best Lipid Fraction for the Prediction of the Population at Risk of Atherothrombotic Disease. William E. Feeman, Jr., M.D.

The recently released American College of Cardiology

Diabetes Day for Primary Care Clinicians Advances in Diabetes Care

Clinical Study of Lipid Profile Pattern in Acute Coronary Syndromes

9/18/2017 DISCLOSURES. Consultant: RubiconMD. Research: Amgen, NHLBI OUTLINE OBJECTIVES. Review current CV risk assessment tools.

Gender-Based and Age-Related Peculiarities of Lipid Metabolism in Chronic Heart Failure Secondary to Overweight and Obesity

Appendix This appendix was part of the submitted manuscript and has been peer reviewed. It is posted as supplied by the authors.

Case Study: Chris Arden. Peripheral Arterial Disease

CVD risk calculation

JUPITER NEJM Poll. Panel Discussion: Literature that Should Have an Impact on our Practice: The JUPITER Study

Pathophysiology of Lipid Disorders

well-targeted primary prevention of cardiovascular disease: an underused high-value intervention?

. Non HDL-c : Downloaded from ijdld.tums.ac.ir at 18:05 IRDT on Friday March 22nd Non HDL LDL. . LDL Non HDL-c

Epidemiologic Measure of Association

8/15/2018. Promoting Education, Referral and Treatment for Patients Presenting with Metabolic Syndrome. Metabolic Syndrome.

Module 2. Global Cardiovascular Risk Assessment and Reduction in Women with Hypertension

Association between Raised Blood Pressure and Dysglycemia in Hong Kong Chinese

Traditionally, clinicians and medical practitioners

The Art of Cardiovascular Risk Assessment

Low-density lipoprotein as the key factor in atherogenesis too high, too long, or both

New Features of the National Cholesterol Education Program Adult Treatment Panel III Lipid-Lowering Guidelines

LDL cholesterol (p = 0.40). However, higher levels of HDL cholesterol (> or =1.5 mmol/l [60 mg/dl]) were associated with less progression of CAC

KEY COMPONENTS. Metabolic Risk Cardiovascular Risk Vascular Inflammation Markers

Latest Guidelines for Lipid Management

2/10/2016. Patient-Centered Management of Dyslipidemia. No disclosures. What is Patient-Centered Management?

Marshall Tulloch-Reid, MD, MPhil, DSc, FACE Epidemiology Research Unit Tropical Medicine Research Institute The University of the West Indies, Mona,

Transcription:

ORIGINAL ARTICLE CARDIOVASCULAR DISEASE RISK FACTOR ESTIMATION IN GUJARATI ASIAN INDIAN POPULATION USING FRAMINGHAM RISK EQUATION Sibasis Sahoo 1, Komal Shah 2,Anand Shukla 3, Jayesh Prajapati 3, Pratik Shah 4 Authors Affiliation: 1 Assistant Professor, Cardiology Department; 2 Research Officer, Research Department; 3 Associate Professor, Cardiology Department; 4 Junior Research Fellow in Research Department;. UN Mehta Institute of Cardiology and Research Center, Ahmedabad Correspondence: Dr. Sibasis Sahoo, Email: sibasissahoo@gmail.com ABSTRACT Introduction: Framingham 10 years risk estimation tools are potentially a cost-effective strategy for cardiovascular disease (CVD) prevention in developing countries. The current investigation was designed to predict CVD risk in healthy and asymptomatic Gujarati Asian Indians. Methods: It was observational study of 2483 individuals of Gujarat state having no past or present history of major illness including CVD. The study cohort was stratified into three groups of low-, intermediate- and high risk of CVD according to the Framingham 10 years risk calculator and the contributing factors for higher CVD risk were studied. Results : Out of 2483 individuals, (65.4%) had low risk of CVD event followed by 21.95% having intermediate and 12.65% showing high risk. The low level of HDL-C (85.03%), hypertension (63.69%) and elevated TC (60.83%) and LDL-C (60.83%) were found to be the main contributors for CVD risk. In high risk males the levels of TC (58.45%) and LDL-C (58.1%) were significantly elevated (p<0.0001), whereas levels of HDL-C (92.25%) markedly low in this subset of population, whereas in females hypertension (100%) and abnormalities of lipids (TC 83.33%, LDL-C 86.67%) were the contributors. The CVD risk increased with age in both the genders where maximum risk was found at the population being in the 60-69 years (male 45.07%; female 46.67%) of the age. Conclusion: Higher risk in Gujarati Asian Indian community is mainly attributed by dyslipidemias and hypertension. Both of them being modifiable risk factors, the life style modification is highly advocated in this ethnic group. Keywords: Gujarati Asians Indians, dyslipidemia, Framingham risk score, hypertension INTRODUCTION Cardiovascular diseases (CVD) are the leading causes of death in most of high-, low-, and middleincome countries. [1,2] In current scenario, area of research dealing with the stratification of individual risk most cost-effective allocation of preventive therapies. As the incidence of CVD is largely explained by reducing modifiable risk factorsthrough health promotion focusing on lifestyle is a logical way of preventing disease [3]. The Framingham risk Score (FRS) has traditionally been used as a predictor of the 10-year risk of CVD [4,5]. The current study was conducted to identify high risk individuals by using a Framingham risk equation [6]. METHODS This observational and randomized screening study, conducted by U. N. Mehta Institute of cardiology and research centre was approved by Institutional ethics committee. Total 2483 individuals of both the genders (1477 males & 1006 females), who were apparently healthy, asymptomatic, disease free and ranging in age from 30 to 74 years were included in the study. The subjects taking any medications and with abnormal stress test were excluded from the investigation. All patients had Volume 4 Issue 4 Oct Dec 2014 Page 293

normal baseline electrocardiography (ECG) and 2D echocardiography. The details of demographic data, ethnicity, family history of CAD and smoking were collected for each individual. Subjects were advised to fast at least for twelve hour before blood investigations. Total cholesterol (TC), triglycerides (TG), total lipid (TL), lipoproteins - low density lipoproteins (LDL), high density lipoprotein (HDL), and very low density lipoprotein (VLDL), and glucose concentrations were measured by International Federation of Clinical Chemistry (IFCC) approved enzymatic methods using commercially available kit on auto analyzer (ARCHITECH PLUS ci4100, Germany). Lipids levels were classified according to the classification recommended by National Cholesterol Education Program (NCEP) and Adult Treatment Panel III (ATP III) guidelines. Blood pressure of the population was measured according to earlier reported guidelines and hypertension was diagnosed if the systolic blood pressure was higher than 140mm Hg or the diastolic blood pressure was above 90 mm Hg [7]. Four categories of body mass index (BMI) (weight in kilogram/the square of height in meters) were designed according to the WHO standards [8]. Framingham risk estimation model is based on age, treated and untreated systolic blood pressure, diabetes, smoking, Body Mass Index (BMI). This tool is designed to determine an individual's chances of developing cardiovascular disease (coronary heart disease or stroke) in adults aged 30 years and older who do not have CVD. Statistical Analysis Data was analysed using SPSS, version 20.0 (SPSS Inc., Chicago, IL, USA). Quantitative data was expressed as mean plus-minus SD whereas qualitative data was expressed in percentage by using SPSS. Comparisons between the groups were done using t test or chi square test wherever appropriate. A p value <0.05 was considered statistically significant. RESULTS The demographic profile of overall population is described in table 1. Mean age of the study group was 46.8 ± 10.35 years where males had significantly (p<0.0001) higher age 47.63 ± 10.77 as compared to females (45.59 ± 9.58). The results indicated that considerably large number of asymptomatic individuals were suffering from dyslipidemias (low HDL-C 61.22%, high LDL-C 40.88%, high TC 39.3%, high triglyceride 10.07%). 13.25% of the population was suffering from obesity and 10.87% of them had habit of smoking. High BMI was found in 13.25% and 4.31% of the population was diabetic in nature. The prominent cardiovascular risk factor found in male were low HDL-C level (88.49%), elevated TC (40.56%) and hypertension (33.99%) where as in females dyslipidemias of TC (37.48%) and LDL-C (37.38%) were widely prevalent. According to Framingham risk calculator the total population of the study group was divided into various categories of low-, intermediate- and high risk of developing cardiovascular diseases in 10 years (table 2). Table 1: Demographic data of the study population Variables Population Male (%) Female (%) P-value Total 2483 1477 (59.48) 1006 (40.51) Age (years) 46.80±10.35 47.63±10.77 45.59±9.58 <0.0001 Total Cholesterol 976(39.31) 599(40.56) 377(37.48) 0.1334 Triglyceride 250(10.07) 191(12.93) 59(5.86) <0.0001 HDL-C 1520(61.22) 1307(88.49) 213(21.17) <0.0001 LDL-C 1015(40.88) 639(43.26) 376(37.38) 0.0039 LDL-C/HDL-C 1157(46.6) 815(55.18) 342(34) <0.0001 TC/HDL-C 1325(53.36) 938(63.51) 387(38.47) <0.0001 TG/HDL-C 555(22.35) 409(27.69) 146(14.51) <0.0001 Total lipid 668(26.9) 461(31.21) 207(20.58) <0.0001 VLDL 369(14.86) 276(18.69) 93(9.24) <0.0001 Smoking 270(10.87) 217(14.69) 53(5.27) <0.0001 BMI ( 30) 329(13.25) 162(10.97) 167(16.6) 0.0001 Diabetes 107(4.31) 75(5.08) 32(3.18) 0.0289 Hypertension 771(31.05) 502(33.99) 269(26.74) 0.0002 Volume 4 Issue 4 Oct Dec 2014 Page 294

Table 2: Categorization of the study population according to Framingham risk Variable Low risk(%) Intermediate risk(%) High risk(%) P-value Total 1624(65.4) 545(21.95) 314(12.65) Total Cholesterol 511(31.47) 274(50.28) 191(60.83) <0.0001 Triglyceride 110(6.77) 64(11.74) 76(24.2) <0.0001 HDL-C 857(52.77) 396(72.66) 267(85.03) <0.0001 LDL-C 529(32.57) 295(54.13) 191(60.83) <0.0001 LDL-C /HDL-C 609(37.5) 325(59.63) 223(71.02) <0.0001 TC/HDL-C 711(43.78) 365(66.97) 249(79.3) <0.0001 TG/HDL-C 280(17.24) 148(27.16) 127(40.45) <0.0001 Total lipid 293(18.04) 177(32.48) 148(47.13) <0.0001 VLDL 176(10.84) 95(17.43) 98(31.21) <0.0001 Smoking 109(6.71) 78(14.31) 82(26.11) <0.0001 BMI ( 30) 214(13.18) 78(14.31) 37(11.78) 0.5684 Diabetes 18(1.11) 33(6.06) 56(17.83) <0.0001 Hypertension 310(19.09) 261(47.89) 200(63.69) <0.0001 Table 3: Gender and risk score wise categorization of the study population Male (%) P-value Female (%) P-value Variables Low Risk Intermediate High Risk Low Risk Intermediate High Risk Total Subjects 760(51.45) 433(29.32) 284(19.23) 864(85.88) 112(11.13) 30 (2.98) TC 232(30.53) 201(46.42) 166(58.45) <0.0001 279(32.29) 73(65.18) 25(83.33) <0.0001 Triglyceride 73(9.61) 50(11.55) 68(23.94) <0.0001 37(4.28) 14(12.5) 8(26.67) <0.0001 HDL-C 676(88.95) 369(85.22) 262(92.25) 0.0132 181(20.95) 27(24.11) 5(16.67) 0.6161 LDL-C 253(33.29) 221(51.04) 165(58.1) <0.0001 276(31.94) 74(66.07) 26(86.67) <0.0001 LDL-C/ HDL-C 365(48.03) 247(57.04) 203(71.48) <0.0001 244(28.24) 78(69.64) 20(66.67) <0.0001 TC/HDL-C 427(56.18) 283(65.36) 228(80.28) <0.0001 284(32.87) 82(73.21) 21(70) <0.0001 TG/HDL-C 173(22.76) 120(27.71) 116(40.85) <0.0001 107(12.38) 28(25) 11(36.67) <0.0001 Total lipid 153(20.13) 128(29.56) 130(45.77) <0.0001 140(16.2) 49(43.75) 18(60) <0.0001 VLDL 110(14.47) 78(18.01) 88(30.99) <0.0001 66(7.64) 17(15.18) 10(33.33) <0.0001 Cigarrate 73(9.61) 67(15.47) 77(27.11) <0.0001 36(4.17) 12(10.71) 5(16.67) 0.0016 BMI ( 30) 74(9.73) 56(12.93) 32(11.27) 0.2325 140(16.20) 22(19.64) 5(16.67) 0.6547 Diabetes 7(0.92) 15(3.46) 53(18.66) 0.0004 11(1.27) 18(16.07) 3(10) <0.0001 Hypertension 161(21.18) 78(18.01) 30(10.56) <0.0001 283(32.75) 78(69.64) 30(100) <0.0001 Figure 1: Framingham risk of CVD in males according to age Figure 2: Framingham risk of CVD in females according to age Volume 4 Issue 4 Oct Dec 2014 Page 295

Out of 2483 individuals, 1624 (65.4%) had low risk of CVD event followed by 21.95% having intermediate and 12.65% showing high risk of CVD. The results indicated that almost all the risk factors possesses increasing trend from low risk to high risk group. Except from high BMI (p=0.5684) other parameters were significantly advanced in high risk group as compared to low risk and intermediate group population. The low level of HDL- C (85.03%), hypertension (63.69%) and elevated TC (60.83%) and LDL-C (60.83%) were the main contributors for higher 10 years coronary artery disease (CAD) risk in Gujarati Asian Indians. Ratios of various lipids (LDL-C/HDL-C - 71.02%, TC/HDL-C 79.3% and TG/HDL-C 40.45%) were significantly (p<0.0001) elevated in high risk group. We have observed that although showed an increasing pattern diabetes was prevalent only in 17.83% of the population being at high risk of CAD. The population was further categorized according to their gender and Framingham risk as presented in table 3. In high risk males the levels of TC (58.45%) and LDL-C (58.1%) were significantly elevated (p<0.0001), whereas levels of HDL-C (92.25%) markedly low in this subset of population. However in females the CVD risk factors involved in advanced risk score were high blood pressure (100%) and abnormalities of lipids (TC 83.33%, LDL-C 86.67%). The CVD risk score of these asymptomatic individuals were also grouped according to their age also and is shown in figure 1 and 2. The result showed that risk of CVD increases with age in both the genders where maximum risk was found at the population being in the 60-69 years (male 45.07%; female 46.67%) of the age group. DISCUSSION The use of risk prediction tools derived from the Framingham Study has been widely recommended to health professionals for the identification of individuals at high risk of cardiovascular disease. The basis of this recommendation is an understanding that the intensity of management of risk factors should be proportional to an individual s absolute risk of experiencing a cardiovascular event. One of the prime finding of this study is the key contribution of various dyslipidemias (high TC - 60.83%, low HDL-C 85.03%, high LDL-C 60.83) and hypertension (63.69%) in CVD risk development in Gujarati Asian Indians. However, in spite of their proven role in VD in other ethnic cohort smoking (26.11%), diabetes (17.83%) and obesity (11.78%) were found to be weakly associated with CAD risk in Gujarati Asian Indians. Disturbance in lipid metabolism often causes manifestation of various dyslipidemias triggering inflammatory processes inducing atherosclerotic disorders. [9] The establishment of relationship between total cholesterol and CHD risk was reported to be one of the first land mark finding of Framingham study. Recently, the cholesterol centric approach to CVD is an obsolete concept as the high levels of LDL, elevated TG, TL, VLDLs and low levels of HDL are also known to contribute in CVD which was later updated by Framingham investigators also. [10] Similarly this study results also showed key association between various dyslipidemias and high framingham risk score in Gujarati Asian Indians. HDL being anti-atherogenic lipoprotein provides cardio-protection through various mechanisms such as reverse transport of cholesterol, preventing endothelial dysfunction and antioxidative properties. Various clinical and epidemiological studies have shown inverse relationship between HDL level and coronary events. [11] HDL abnormality was found to target the population at relatively early age in both the gender indicating early need for diet and life style modification. Hypertension is one of the strongest attributable risk factor of CVD and several epidemiological studies such as INTERHEART and Framingham had recommended its use as a powerful predictor of future CVD events. [10,12] In the same manner this study also founds hypertension as one of the strongest predictor of high CVD risk showing higher frequencies (high risk group) in females (100%) as compared to male (10.5%), which is in accordance with earlier reported studies. [13] This remarkable loss of the estrogen protective effect in Gujarati females could be partially explained by less effective baroreflex buffering of blood pressure in women than men and presence of associated comorbidities. [14] The overall population affected by high blood pressure reported in our study (31.05%) was relatively higher than other documented studies (16.9%). [15] We have observed that the risk of CVD increases with increasing age making natural aging as one of the risk factor for CVD event. Natural ageing allied increase in CVD risk was observed in both the genders in the current study as reported by others also for Gujarati Asian Indians. Ageing induces dysfunctional arteries by increasing arterial stiffness, oxidative stress and reducing arterial compli- Volume 4 Issue 4 Oct Dec 2014 Page 296

ance and promotes CVD risk factors. [16] Our results clearly states that the as people grow older CVD risk increases due to greater expression of Framingham equation risk factors, namely dyslipidemias and hypertension. CONCLUSION The present study states that 12.65% of the Gujarati Asian Indian community had higher CVD risk that is mainly contributed by various dyslipidemias and hypertension. The risk was higher in males and older population. This information could be used for designing of preventive strategies for modifiable risk factors of CVD - dyslipidemias and hypertension in this ethnic group of individuals. Source of support: U. N. Mehta Institute of Cardiology and Research Center (affiliated to BJ medical college, Ahmedabad) REFERENCES 1. Alwan AD, Galea G, Stuckler D. Development at risk: addressing noncommunicable diseases at the United Nations high-level meeting: Bull World Health Organ 2011;89(8):546-546A. 2. Gaziano TA, Young CR, Fitzmaurice G, Atwood S, Gaziano JM. Laboratory-based versus non-laboratory-based method for assessment of cardiovascular disease risk: the NHANES I Follow-up Study cohort. Lancet 2008;371(9616):923-31. 3. Ebrahim S, Taylor F, Ward K, Beswick A, Burke M, Davey Smith G. Multiple risk factor interventions for primary prevention of coronary heart disease. Cochrane Database Syst Rev 2011;19 4. Lloyd-Jones DM. Cardiovascular risk prediction: basic concepts, current status, and future directions. Circulation 2010;121(15):1768-77. 5. Grundy SM, Bazzarre T, Cleeman J, D'Agostino RB, Sr., Hill M, Houston-Miller N, et al. Prevention Conference V: Beyond secondary prevention: identifying the highrisk patient for primary prevention: medical office assessment: Writing Group I: Circulation 2000;101(1):E3- E11. 6. Framingham Heart Study: http://www.framinghamheartstudy.org/risk/gencardio.html. 7. Indian Consensus Group. Indian consensus for prevention of coronary artery disease: A joint scientific statement of Indian society of hypertension and International College of Nutrition. J Nutr Environ Med 1996; 6: 309-18. 8. Organization WH. The World health report: 2002: reducing risks, promoting healthy life: overview 2002. 9. Faxon DP, Fuster V, Libby P, Beckman JA, Hiatt WR, Thompson RW, et al. Atherosclerotic Vascular Disease Conference: Writing Group III: pathophysiology. Circulation 2004;109(21):2617-25. 10. O'Donnell CJ, Elosua R. Cardiovascular risk factors. Insights from Framingham Heart Study. Rev EspCardiol 2008;61(3):299-310. 11. Rye KA, Bursill CA, Lambert G, Tabet F, Barter PJ. The metabolism and anti-atherogenic properties of HDL. J Lipid Res 2009;50(200):24. 12. Ajay VS, Prabhakaran D. Coronary heart disease in Indians: implications of the INTERHEART study. Indian J Med Res 2010;132:561-6 13. Momin MH, Desai VK, Kavishwar AB. Study of sociodemographic factors affecting prevalence of hypertension among bank employees of Surat City. Indian J Public Health 2012;56(1):44-8. 14. Tiwari RR. Hypertension and epidemiological factors among tribal labour population in Gujarat. Indian J Public Health 2008;52(3):144-6. 15. Christou DD, Jones PP, Jordan J, Diedrich A, Robertson D, Seals DR. Women have lower tonic autonomic support of arterial blood pressure and less effective baroreflex buffering than men. Circulation 2005;111(4):494-8. 16. Lee S-J, Park S-H. Arterial Ageing. Korean circulation journal 2013;43(2):73-9. Volume 4 Issue 4 Oct Dec 2014 Page 297